Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study.

Background: In the Île-de-France region (henceforth termed Greater Paris), extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) was considered early in the COVID-19 pandemic. We report ECMO network organisation and outcomes during the first wave of the pandemic.

Methods: In this multicentre cohort study, we present an analysis of all adult patients with laboratory-confirmed SARS-CoV-2 infection and severe ARDS requiring ECMO who were admitted to 17 Greater Paris intensive care units between March 8 and June 3, 2020.

MCR-1 and OXA-48 Acquisition in KPC-Producing Escherichia coli after Colistin Treatment.

The spread of -encoding plasmids into carbapenem-resistant raises concerns about the emergence of untreatable bacteria. We report the acquisition of in a carbapenem-resistant strain after a 3-week course of colistin in a patient repatriated to France from Portugal. Whole-genome sequencing revealed that the carbapenemase-producing strain acquired two plasmids, an IncL OXA-48-encoding plasmid and an IncX4 -encoding plasmid.